Abstract
Professional as well as patient-oriented societies have contributed significantly to the development of understanding and management of patients with neuroendocrine tumors. The European Neuroendocrine Tumor Society (ENETS) has been an icebreaker for the development of guidelines and classification systems for these heterogeneous tumors and has been followed by other international societies such as the North American Neuroendocrine Tumor Society (NANETS), Asia Pacific Neuroendocrine Tumour Society (AP-NET), and Latin American Neuroendocrine Tumor Society (LANETS). All international societies have contributed to (specific) guidelines with specific twists for their own region. The development of an accreditation system for centers of excellence by the ENETS has significantly improved the management of patients with neuroendocrine tumors. Patient organization societies have been very important support groups for the professional societies and also significantly contributed to the increased knowledge about these diseases among patients with NETs.
Further development of collaboration between the different societies will be of clear benefit to patients with neuroendocrine tumors and contribute to development of new diagnostic and therapeutic procedures.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Yao JC et al (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063–3072
Rindi G et al (2006) Consensus guidelines for the management of patients with digestive neuroendocrine tumors: why such guidelines and how we went about It. Neuroendocrinology 84(3):155–157
Bosman FT, Carneiro F (2010) WHO classification of tumours, pathology and genetics of tumours of the digestive system. IARC Press, Lyon
Kulke MH et al (2010) NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39(6):735–752
Oberg K et al (2010) Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v223–v227
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Öberg, K. (2015). Societies and Guidelines for Neuroendocrine Tumors. In: Yalcin, S., Öberg, K. (eds) Neuroendocrine Tumours. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45215-8_33
Download citation
DOI: https://doi.org/10.1007/978-3-662-45215-8_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45214-1
Online ISBN: 978-3-662-45215-8
eBook Packages: MedicineMedicine (R0)